FUNCT PLANT BIOL 润色咨询

FUNCTIONAL PLANT BIOLOGY

出版年份：2002 年文章数：2434 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：4.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2019-01-31 蜜蜜

    3个月还在1审，着急

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2019-07-22 周佩娜

    我也想问 需要版面费吗 好像不用155****6352(暂无匿称) 2018-02-27 发表::
    你好.我想问下这个期刊收版面费吗?     155****6352(暂无匿称) 2018-02-27 23:08:00 发表:
    你好.我想问下这个期刊收版面费吗?

    155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2021-12-28 rayms

    我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    如何申请延期？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2018-02-27 1ddaf754m52(暂无匿称)

    你好.我想问下这个期刊收版面费吗? ding_ying 2017-07-18 发表::
    SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??

    ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2017-07-18 ding_ying

    太狠了！跌了这么多，以后谁还敢投？？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2015-01-21 LJ55613

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2013-07-06 ms2614478266438915

    2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2012-11-28 qupeter

    明年能不能冲到3分？大家谈谈

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=566382, encodeId=dde4566382ad, content=3个月还在1审，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVROUuRe59GKDQX6pYlFjQqln28mzSVbsliaBjaWChQNTnMH1frPEL9hX6rE7uRuRWLhz4jzJtA5A/132, createdBy=61452502301, createdName=蜜蜜, createdTime=Thu Jan 31 22:15:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573913, encodeId=73875e39135a, content=我也想问 需要版面费吗 好像不用<span class="quote">155****6352(暂无匿称) 2018-02-27 发表::<br>你好.我想问下这个期刊收版面费吗? </span><span class="quote">155****6352(暂无匿称) 2018-02-27 23:08:00 发表:<br>你好.我想问下这个期刊收版面费吗? </span>, beContent=155****6352(暂无匿称) 2018-02-27 发表:: 你好.我想问下这个期刊收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/31/3ddccbe935551b6ed865997400358cbc.jpg, createdBy=c4c92296560, createdName=周佩娜, createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099095, encodeId=8f20109909599, content=我的俢回什么时候截止？截止日期是否可以变动/截止日期就是期刊真正要求的日期么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099096, encodeId=c7411099096ed, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553080, encodeId=a0b6553080f9, content=你好.我想问下这个期刊收版面费吗? <span class="quote">ding_ying 2017-07-18 发表::<br>SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??</span>, beContent=ding_ying 2017-07-18 发表:: SCI(2014):3.145SCI(2015):2.491SCI(2016):2.121 太狠了!跌了这么多.以后谁还敢投??, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace81643791, createdName=1ddaf754m52(暂无匿称), createdTime=Tue Feb 27 23:08:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540293, encodeId=d9fe540293fb, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509283, encodeId=b74150928376, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑很负责啊，第一天中午投的稿，第二天就认真审核并给予回复，然后直接被拒稿了……这个期刊要求较大的创新性，鼓励多学科交叉研究，研究某一特定植物特定基因且没有全新突破点的，就不用试了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f01612272, createdName=LJ55613, createdTime=Wed Jan 21 11:21:00 CST 2015, time=2015-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826699, encodeId=bd21826699b1, content=2013年5月14号投稿，现在还在审稿，已经50天了，不知道这个进度是快还是慢，不过已经上传了版权转让协议。期待能有好的消息！这篇文章对我来说至关重要！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sat Jul 06 08:24:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492583, encodeId=8e8f492583d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488499, encodeId=bc0048849997, content=非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 19 22:43:00 CST 2012, time=2012-05-19, status=1, ipAttribution=)]
    2012-05-19 匿名用户

    非常好的期刊，很多经典的植物同位素生理机制的文章，不过近年也开始往分子倾斜

    0

共23条页码: 1/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分